Considering that β-catenin can acts as a transcriptional regulator upon the genes of cyclin D1, c-Myc, MMP2, and MMP7 (34–37), we hypothesized that DHC might exert anti-cancer activity via a β-catenin dependent way. Here, CCND1 is linked to cancer.